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Abstract 
Purpose: To evaluate the in vitro and in vivo anti-leishmanial and cytotoxic activities of extracts of 
different parts of Lawsonia Inermis, Morus nigra and Ziziphus mauritiana. 
Methods: The methanol extracts of all three plant materials at concentrations of 10 - 100 µg/mL were 
tested for their in vitro anti-leishmanial effects on L. tropica KWH23 promastigotes for 24 - 48 h, relative 
to negative control and amphotericin-B (standard drug). For in vivo anti-leishmanial activity, the extracts 
were tested against L. tropica-infected albino mice, while cytotoxicity was investigated against 
mammalian cells (lymphocytes). 
Results: For Lawsonia Inermis leaves, mean inhibition of extracellular promastigotes at 10, 25, 50 and 
100 µg/mL after 48 h were 98.2 ± 0.06, 98.75 ± 1.09, 99.31 ± 0.00 and 100.00 ± 0.00 %, respectively. 
After 8 weeks, mean lesion size decreased from 0.8 ±  0.2 mm to 0.3 ±  0.1 mm (p < 0.01), and cure at 
150 mg/kg against intracellular amastigotes in albino mice was 97.02 % (95 % CI = 96.14 - 98.10). IC50 
for Lawsonia inermis leaf extract was 12.22 µg/mL (95 % CI = 11.54 - 13.84) against lymphocytes. 
Conclusion: The results obtained in this study show that Lawsonia Inermis leaf is safe and possesses 
potent anti-leishmanial activity. 
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Lawsonia inermis is commonly known as Henna 
(Family Lythraceae). It is native to Northern 
Africa and South-Western Asia, and is cultivated 
in many tropical and sub-tropical regions. 
Different parts of the plant, especially the leaves, 
flowers, stem bark and roots have been used as 
traditional medicine for years. Phytochemical 
composition of the plant include flavonoids,  
coumarins, alkyl phenones, terpenes (volatile 
terpenes, non-volatile terpenes), aliphatic 
hydrocarbons, and alkaloids, all of which 
possess a variety of pharmacological activities, 
including antioxidant, antiviral and anti-parasitic 
[1-5]. 
 
Morus nigra (local name: Shahtoot) belongs to 
the family Moraceae. It is widely distributed in 
Asia, Africa, America (North and South Areas) 
and Europe. Its root, twigs, bark and fruits 
contain phenolic compounds used to treat 
asthma. Studies have reported that the plant is 
rich in isoprenylated flavonoids, triterpenes and 
saponins, which have antioxidant, antibacterial 
and anticancer activities [6-8]. Ziziphus 
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mauritiana (local name: Ber) is a fruit tree which 
belongs to family Rhamnaceae. Its fruit has been 
used as a medicament for wound and ulcer 
healing, and as a sedative. Different parts of the 
plant exhibit pharmacological activities due to the 
presence of alkaloids, triterpenoids, and 
saponins, which are reported to have 
antimicrobial and antioxidant activities [9-13]. 
 
In this study, anti-leishmanial activities of 
different parts of Lawsonia inermis, Morus nigra 
and Ziziphus mauritiana were were investigated 
against Leishmania tropica promastigotes and 
amastigotes. The cytotoxic effects of the extracts 






Fetal bovine serum (FBS), dimethyl sulfoxide 
(DMSO), RPMI-1640 medium, amphotericin B, 
penicillin, streptomycin, formic acid, analytical 
grade solvents (ethanol, methanol and acetone) 
were purchased from Sigma-Aldrich (St. Louis, 
MO, USA). Water used for analysis was purified 
by deionization and 0.22 µm membrane filtration 
(Millipore, Billerica, MA, USA). 
 
Collection of plant material and preparation 
of crude extract 
 
Lawsonia inermis leaves (LIL), stem bark (LISB) 
and seed (LIS); Morus nigra leaves (MNL) and 
stem bark (MNSB); and Ziziphus mauritiana 
leaves (ZML) and stem bark (ZMSB) were 
collected from the territory of Dera Ismail Khan, 
Khyber Pakhtunkhwa (KPK), Pakistan between 
August and September 2015. The plants were 
identified by Dr Siraj–ud-Din, Department of 
Botany, University of Peshawar, and voucher 
specimens [Bot, 200101 (pup), 200102 (pup), 
and 200106 (pup)] were deposited in the 
Herbarium of the Department. Each plant 
material was washed with distilled water before 
shade-drying at temperatures below 35 °C. The 
dried material was ground to powder and stored 
in a cool dark place until use. Crude extract was 
obtained by soaking 1 kg of powdered material in 
2 liters of methanol for 1 week, with regular 
stirring. The extract was first filtered through 
muslin cloth, and then through Whatman filter 
paper no. 41. The filtrate was concentrated under 





The extracts were screened for phytochemical 
composition in accordance with the TLC method 
of Stahl [14] by Benedict reagent (flavonoid and 
coumarin test), Dragendorff’s reagent (alkaloid 
test), benzidine (phenol test), amide test and 
Kedde reagent (glycoside test). 
 
In vitro anti-leishmanial activity 
 
In vitro anti-leishmanial activities of LIL, LISB, 
LIS, MNL, MNSB, ZML, and ZMSB extracts were 
tested with clinical isolate of Leishmania tropica 
promastigotes (KWH23, now Pakistani clinically 
isolated strain, UOP) according to growth 
inhibition assay described by Iqbal et al [15]. 
Promastigotes of Leishmania tropica were 
cultured in RPMI-1640 medium containing 10 % 
fetal bovine serum, 200 U/mL of penicillin, and 
0.2 mg/mL of streptomycin. The parasites were 
cultured at 26 °C for 4 days in BOD incubator 
(Gallenkamp, size 1, UK), after which the 
promastigotes were harvested in sterile tubes. 
Viable cell count was done by transferring 5 - 10 
µl of the promastigotes to a haemocytometer 
(Reichert, New York, U.S.A), and enumerating 
them under upright microscope (CX31, Olympus, 
Tokyo, Japan). The number of promastigotes 
(viable cell count, Vw) was calculated as in Eq 1. 
 
Vw (live cells/ml) = C/L)D104 ………………. (1) 
 
where C is number of live cells counted, L the 
number of large corner squares counted, and D 
is the dilution factor used 
 
The harvested promastigotes were subsequently 
centrifuged at 2000 rpm for 10 min at 4 oC; the 
supernatant was removed, and the pellet 
reconstituted in fresh RPMI-1640 medium 
containing 10 % FBS to obtain a concentration of 
1.4 × 106 promastigotes/mL in the required 
volume (10 mL). This was dispensed (10 µl), 
using multiple pipettes, into 96-well culture plate 
containing the plant extracts in separate wells at 
three different concentrations (10, 25, 50 and 
100 µg/mL), mixed and left in BOD incubator at 
26 °C for two days. Thereafter, the 
promastigotes were counted under upright 
microscope (lens 40x) at 24 and 48 h in a 
haemocytometer. The in vitro anti-leishmania test 
was performed in triplicate and the mean 
percentage inhibition of parasite was obtained. 
 
In vivo anti-leishmania assay 
 
Male BALB/c mice (20-32 g; aged 6-8 weeks) 
were used. The mice were supplied by 
Department of Pharmacology Animal Center, 
University of Peshawar, KPK, Pakistan. 
Leishmania tropica KWH23 promastigotes were 
cultured in RPMI-1640 medium containing 10 % 
fetal bovine serum, 200 U/mL penicillin and 0.2 
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mg/mL streptomycin. The parasite was cultured 
and multiplied at 26 °C for 4 days in BOD 
incubator and harvested. The harvested 
promastigotes were taken in sterile tubes and 
counted in a haemocytometer under upright 
microscope. Then the promastigotes were 
centrifuged at 2000 rpm for 10 min at 4 °C. The 
supernatant was discarded, while the pellet was 
diluted to 10 mL with fresh RPMI-1640 medium 
containing 10 % FBS. This was injected (10 µL) 
intraperitoneally into the cardiac cavity of BALB/c 
mice. Development of lesion was measured 
weekly with dial micrometer during the infection 
period. Infection was well established and lesions 
were clearly visible to the naked eye after 36 
days. Treatment with the extracts started at this 
stage. 
 
9 groups (n=6) of BALB/c mice were used, out of 
which 7 groups comprised extract-treated, 1 
group was standard drug, and 1 group was 
negative control. The extracts were dissolved in 
DMSO and administered separately to groups I, 
II, III, IV, V, VI and VII at a dose of 30 mg/kg for 5 
days (each group received one extract only). 
Amphotericin was used as standard drug at a 
dose of 15 mg/kg. No drug agent was used in 
group VIII (negative control). The drug was 
administered five times to each mice at 3-day 
intervals and result was recorded regularly. Dial 
micrometer was used to note the differences 
between sizes of the lesion in infected and 
uninfected mice weekly. Before and after 
treatment, needle aspirations of samples were 
taken from infection/lesion areas [15]. For 
detection of amastigotes under the light 
microscope, Giemsa stain was used under oil 
immersion. On 48th, 60th and 90th days post-
infection, 60 mg of tissue sample was taken from 
lesion zones for biopsy. Each sample was 
smeared on slides stained with Giemsa and 




This study was approved by Animal and Ethics 
Committee, Faculty of Pharmacy and Health 
Sciences, University of Balochistan (UOB), 
Quetta (approval ref. no. 093/FOPHS/UOB). The 
animals were maintained in accordance with 
UOB, Quetta Policy and international guidelines 
on the care and use of laboratory animals [16]. 
Standard diet and water were given ad libitum to 




Fresh blood (10 mL) was taken in BD Vacutainer 
K2E (EDTA) from a healthy volunteer as a 
source of mammalian cells (lymphocytes) for 
cytotoxic analysis of extracts. The lymphocytes 
were isloated according to the method outlined 
by Bøyum [15,17]. Extracts were added at 
concentrations of 100, 50, 25 and 10 µg/mL in 
DMSO. Amphotericin (25 µg/mL) served as 
reference drug, while negative control was 
Leishmania tropica KWH23 promastigotes. Using 
a multipipette, equal concentration of 
promastigotes (1.4 x 106 promastigotes/mL) was 
put in each well of a 12-well culture plate, which 
was then incubated at 26 °C for 48 h. Viable 
lymphocytes and promastigotes were counted 
under light microscope (lens 40x) at 24 and 48 h. 
The cytotoxic test was carried out in triplicate, 




Inhibition (%) of parasite growth was expressed 
as mean ± SD (n = 3). Cytotoxic activity was 
expressed as 50 % inhibitory concentration (IC50) 
and analysed by non-linear regression analysis. 
For in vivo assays, mean lesion size (mm) and 
percentage cure rate were analysed with 
GraphPad Prism 5 software (GraphPad software, 





Phytochemical profile of plant extracts 
 
Methanolic extract of Morus nigra stem bark 
exhibited highest extraction yield of 30.35 % 
while the lowest yield of 9.32 % was seen in 
leaves of Lawsonia inermis. The yields for all 
extracts are shown in Table 1. 
 
         Table 1:  Yield of methanol plant extracts 
 

















Terpenoids, Flavonoids, Alkaloids 
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In vitro antileishmanial activity 
 
The extracts produced inhibition ranging between 
22 and 66.1 at 10 µg/mL, while at 100 µg/mL, 
inhibition ranged between 39.06 and 93 % (Table 
2). At 48 h, inhibition ranged between 40.09 and 
98.2 at 10 µg/mL, and between 60.01 and 100 % 
at 100 µg/mL. Methanol extract of Lawsonia 
inermis leaves and seed exhibited highest 
activities (100 %) at 100 µg/mL. Lawsonia 
inermis stem bark showed promising inhibitory 
activity, with 98 % at 100 µg/mL. In comparison 
with negative control (NC), except for 24th hour 
analysis of Morus nigra (stem bark and leaves) 
and Ziziphus mauritiana (leaves and stem bark) 
with parasitic inhibition ranging between 39.06 
and 50.09 % at 100 µg/mL, all extracts showed 
promising parasite inhibition against L. tropica. 
Lawsonia inermis showed the most significant 
results, ranging between 90 and 93 % anti-
leishmanial activity after 24 h at 100 µg/mL. 
 
In vivo anti-leishmanial activity  
 
In vivo anti-leishmanial activities of LIL, LISB, 
LIS,MNL, MNSB, ZML, and ZMSB in albino mice 
infected with 0.02 mL clinically isolated L. tropica 
KWH23 having 1.4 x 106 promastigotes via 
intraperitoneal route, showed promising results 
after 36-120 days (Table 3). In six (6) sample 
groups, mean lesion size of mice decreased 
significantly from 0.5 ± 0.51 mm to 0.3 ± 0.9 mm 
after treatment with the plant extracts, but the 
mean lesion size of the negative group reached 
1.5 ± 0.5 mm (p > 0.05), whereas in 
amphotericin-B group, it decreased from 0.95 ± 
0.6 mm to 0.35 ± 0.6 mm, at the end of 8th week. 
 
 
Table 2: In vitro anti-leishmanial activity of plant extracts  
 
Sample Sample concentration 
(µg/mL) 
Inhibition (%) 
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(after 8 weeks) 











LIL 30mg/kg 0.8±0.2 0.3±0.1 97.022 
(96.136-98.097) 
6/6 ≥60 
LISB 30mg/kg 0.6±0.3 0.4±0.7 85.27 
(84.205-86.84) 
5/6 ≥60 
LIS 30mg/kg 0.5±0.8 0.3±0.9 90.51 
(89.61-91.89) 
6/6 ≥60 
MNL 30mg/kg 0.85±0.1 0.71±0.3 60.194 
(61.002-63.671) 
3/6 ≥60 
ZML 30mg/kg 0.72±0.2 0.60±0.2 75.02 
(74.96-76.39) 
4/6 ≥60 




Amp 15mg/kg 0.95±0.6 0.35±0.6 95.00 
(94.583-96.02) 
6/6 ≥60 
NC 30mg/kg 0.7±0.5 1.5±0.5 0.000 0/6 ≥0 
Data are mean lesion size (mm) ± SD 
 
Mice that received methanol extract of Morus 
nigra leaves, Ziziphus mauritiana leaves and 
Ziziphus mauritiana stem bark had mean lesion 
size of 0.71 ± 0.3 mm, 0.60 ± 0.2 mm and 0.5 ± 
0.51 mm, respectively; with corresponding % 
cure of 60.194 %, 75.02 % and 70.151 % 
respectively after 8 weeks of treatment. The 
average mean lesion size observed for the mice 
treated with Lawsonia inermis leaves, stem bark 
and seed extracts decreased to 0.3 ± 0.1, 0.4 ± 
0.7, and 0.3 ± 0.9 mm respectively, 
corresponding to a cure of 97.022, 85.27 and 
90.51 %, respectively. It is evident that from the 
results that Lawsonia inermis leaves and seed 
exhibited potent in vivo anti-leishmanial activities 
against L. tropica. 
 
Table 4: Cytotoxic Effect of Plant extract. Data 
represent IC50 (µg/ml) with 95 % confidence limit 
 
Sample Inhibition (µg/ml, CI)  
LIL 12.215 (11.543-13.841) 
LISB 14.752 (13.286-14.751) 
LIS 15.312 (14.013-15.992) 
MNL >100 





LIL, LISB, LIS, MNL, ZML, and ZMSB showed 
moderate in vitro cytotoxic effects against 
lymphocytes after 24-48 h (Table 4). Methanol 
extract of Morus nigra leaves and Ziziphus 
mauritiana leaves and stem bark showed highest 
cytotoxic activities at a concentration of more 
than 100 µg/mL. Lowest cytotoxic activity was 
observed when Lawsonia inermis leaves, stem 
bark and seed extract were exposed to 
lymphocytes, with IC50 values of 12.215, 14.752 




In this work, methanol was selected as a solvent 
for extraction due to its polar nature. All parts of 
Lawsonia inermis showed in vitro inhibition 
ranging between 98.96 ± 0.00 and 100 ± 0.00 at 
100 µg/ml concentration (p < 0.01) after 48 
hours. This is in agreement with anti-leishmanial 
activity of the plant as reported previously [18]. It 
is known that Lawsonia inermis possesses 
secondary metabolites such as flavonoids, 
tannins, coumarins, terpenes, saponins and 
alkaloids [2,6,10]. These phytochemicals might 
be responsible for the observed antileishmanial 
and cytotoxic activities against L. tropica. 
 
Lawsonia inermis possessed significant in vitro 
and in vivo activity against L. tropica 
promastigotes at levels higher than those of 
Morus nigra, Ziziphus muaritiana and 
Amphotericin-B. Most albino mice were cured 
within 120 days of infection, when extract of 
Lawsonia inermis was given, with mean lesion 
size decreased up to 0.3 ± 0.1 mm after the 8th 
week. This curative effect may be due to extract-
induced death of promastigotes/amastigotes 
through inhibition of metabolic pathways of L. 
tropica strains. The cytotoxic effect of Lawsonia 
inermis leaves was lower (IC50 value: 12.215 
µg/mL) when compared with other tested plant 
extracts. 
 
However the observed cytotoxic effect of 
Lawsonia inermis is consistent with previous 
reports on its cytotoxicity against Hep G2 and 
MCF – 7 [19]. 
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Although different biological activities related to 
these plants have been reported in literature, this 
is the first time that a comprehensive study in 
respect of in vitro, in vivo and cytotoxic activities 
of Lawsonia inermis (leaves, stem bark and 
seed), Morus nigra leaves, and Ziziphus 
mauritiana (leaves and stem bark) are reported 




The findings of this study indicate that the leaves 
of Lawsonia inermis possess potent anti-
leishmanial properties against L. tropica, 
probably due to the presence of tannins, 
flavonoids, coumarins and terpenes. This plant 
offers some promise as a source of newer and 
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